As shown in Fig. 4, breast cancer patients with gain or amplification of TRAF6 (n = 213) exhibited significantly lower overall survival rate compared to patients that are diploid (n = 1738) (p < 0.05). This evidence concerns the gene TRAF6 and breast carcinoma.